Common use of Marking Clause in Contracts

Marking. Licensee, its Affiliates, and any Sublicensees shall ▇▇▇▇ any Licensed Product (or their containers or labels) made, sold, or otherwise distributed by it or them with any notice of patent rights necessary or desirable under applicable law to enable the Licensed Patents to be enforced to their full extent in any country where Licensed Products are made, used, sold, offered for sale, or imported.

Appears in 33 contracts

Sources: License Agreement, License Agreement, Option and License Agreement

Marking. Licensee, its Affiliates, and any Sublicensees shall ▇▇▇▇ any Licensed Product (or their containers or labels) made, sold, or otherwise distributed by it or them under this Agreement with any notice of patent rights necessary or (to the extent commercially feasible and consistent with prevailing business practices) desirable under applicable law to enable the Licensed Commercial Patents to be enforced to their full extent in any country where Licensed Products are made, used, sold, offered for sale, or imported.

Appears in 5 contracts

Sources: License Agreement (Voyager Therapeutics, Inc.), License Agreement (Voyager Therapeutics, Inc.), License Agreement (REGENXBIO Inc.)

Marking. Licensee, its Affiliates, and any Sublicensees shall ▇▇▇▇ any Licensed Product (or their containers or labels) made, sold, or otherwise distributed by it or them with any notice of patent rights necessary or desirable under applicable law to enable the Licensed Commercial Patents to be enforced to their full extent in any country where Licensed Products are made, used, sold, offered for sale, or imported.

Appears in 3 contracts

Sources: License Agreement (Adverum Biotechnologies, Inc.), License Agreement (REGENXBIO Inc.), License Agreement (REGENXBIO Inc.)

Marking. Licensee, its Affiliates, Licensee agrees to ▇▇▇▇ and to require any Sublicensees shall Affiliate or Sublicensee to ▇▇▇▇ any Licensed Product Products (or their containers or labels) made, sold, or otherwise distributed by it or them with any notice of patent rights necessary or desirable under applicable law to enable the Licensed Patents Patent Rights to be enforced to their full extent in any country where Licensed Products are made, used, sold, or offered for sale, or imported.

Appears in 2 contracts

Sources: Exclusive License Agreement (Acceleron Pharma Inc), Exclusive License Agreement (Acceleron Pharma Inc)

Marking. Licensee, its Affiliates, and any Sublicensees its and their sublicensees shall ▇▇▇▇ any Licensed Product (or their containers or labels) made, sold, or otherwise distributed by it or them with any notice of patent rights necessary or desirable under applicable law to enable the Licensed Patents to be enforced to their full extent in any country where Licensed Products are made, used, sold, or offered for sale, or imported.

Appears in 2 contracts

Sources: Licensing Agreement (REGENXBIO Inc.), Licensing Agreement (REGENXBIO Inc.)

Marking. Licensee, its Affiliates, Licensee agrees to ▇▇▇▇ and to require any Sublicensees shall Affiliate or Sublicensee to ▇▇▇▇ any Licensed Product Products (or their containers or labels) made, sold, or otherwise distributed by it or them with any notice of patent rights necessary or desirable under applicable law to enable the Licensed Patents Patent Rights to be enforced to their full extent in any country where Licensed Products are made, used, sold, or offered for sale, or imported.

Appears in 2 contracts

Sources: License Agreement (Merrion Pharmaceuticals LTD), License Agreement (Merrion Pharmaceuticals LTD)

Marking. Licensee, its Affiliates, and any Sublicensees shall Licensee agrees to ▇▇▇▇, and to require all Affiliates and Sublicensees to ▇▇▇▇, any Licensed Product Products (or their containers or labels) made, sold, sold or otherwise distributed by it or them with any notice of patent rights necessary or desirable under applicable law (Including the numbers of issued U.S. patents included in the Licensed Patent Rights) to enable the Licensed Patents Patent Rights to be enforced to their full extent in any country where Licensed Products are made, used, sold, sold or offered for sale, or imported.

Appears in 2 contracts

Sources: Exclusive FXR License Agreement (Metacrine, Inc.), Exclusive FXR License Agreement (Metacrine, Inc.)

Marking. Licensee, its Affiliates, and any Sublicensees shall ▇▇▇▇ any Licensed Product (or their containers or labels) made, sold, or otherwise distributed by it or them with any notice of patent rights necessary or desirable under applicable law to enable the Licensed Patents to be enforced to their full extent in any country where Licensed Products are made, used, sold, offered for sale, or imported.

Appears in 2 contracts

Sources: License Agreement (REGENXBIO Inc.), License Agreement (REGENXBIO Inc.)

Marking. Licensee, its Affiliates, and any Sublicensees shall m▇▇▇ any Licensed Product (or their containers or labels) made, sold, or otherwise distributed by it or them with any notice of patent rights necessary or desirable under applicable law to enable the Licensed Patents to be enforced to their full extent in any country where Licensed Products are made, used, sold, offered for sale, or imported.

Appears in 1 contract

Sources: License Agreement (Abeona Therapeutics Inc.)